This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: The Brigham and Women's Hospital, Inc., Dana-Farber-Cancer Institute Inc., Duke University. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 1,428 
3 out of 1,268 
1 out of 2,084 
Years Active: 2012-2020
Title: The Innovative Mind of Ross L. Stein
Introduction
Ross L. Stein is an accomplished inventor based in Cambridge, MA, known for his significant contributions to the fields of cancer treatment and metabolic disorders. With a total of six patents to his name, he has made impactful strides in the biopharmaceutical industry, focusing on innovative solutions that address critical health challenges.
Latest Patents
Among his latest inventions, one noteworthy patent is titled "Small molecule inhibitors of USP1 deubiquitinating enzyme activity." This invention provides small molecule inhibitors of ubiquitin-specific protease 1 (USP1) activity, offering methods for their use in treating and characterizing cancers. The inhibitors developed by Stein are particularly valuable for treating cancers resistant to DNA cross-linking agents, showcasing his commitment to advancing cancer therapies.
Another significant patent from Stein is related to "Phosphatidylcholine transfer protein inhibitors." This invention encompasses compounds of specific formulas and their application as inhibitors of phosphatidylcholine transfer protein (PC-TP). The invention presents pharmaceutical compositions and methods for treating disorders associated with PC-TP inhibition, including obesity and related health issues.
Career Highlights
Ross L. Stein has worked with esteemed institutions such as Brigham and Women's Hospital, Inc. and Dana-Farber Cancer Institute Inc., where he contributed to groundbreaking research and innovative medical solutions. His dedication to enhancing patient outcomes through scientific exploration and invention has garnered him recognition in the field.
Collaborations
Throughout his career, Stein has collaborated with notable colleagues, including Gregory D. Cuny and Marcie A. Glicksman. These partnerships have played a crucial role in the development of his patents and research initiatives, demonstrating the power of teamwork in pushing the boundaries of medical science.
Conclusion
Ross L. Stein's work stands as a testament to the impact of innovation in addressing critical health challenges. His patents reflect a strong commitment to advancing medical treatments, particularly in oncology and metabolic disorders. As he continues to explore new frontiers in biopharmaceutical research, the contributions of inventors like Stein remain pivotal in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile